Microbiology & Virology

Rethink the lateral flow test roll-out?

Professor Iain Buchan argues that lateral flow tests have been misunderstood and are a useful tool in the fight against COVID-19.

Diagnostic legislation changes

Pathology Quality Manager Jessica Dixon looks at safety and quality assurance practices in relation to expanded testing due to the pandemic.

First test for all known human coronaviruses

Scientists at the Centre for Infection and Immunity (CII) at Columbia University Mailman School of Public Health and Sun Yat-sen University in China have set the stage for the development of highly sensitive antibody tests for infection with all known human coronaviruses, including new variants of SARS-CoV-2. 

SARS-COV-2 spike mutations and infectivity

Researchers at the Francis Crick Institute have compared the original SARS-CoV-2 spike protein with a mutated version that arose last spring. 

Laboratory-based coronavirus research

An international consortium has created an openly available SARS-CoV-2 lab research toolkit.

Neurological reverbertions

Dr Maxime Taquet discusses his research into COVID-19 and secondary neurological and psychiatric conditions.

The big question: How do you think the public has coped with the last year of lockdowns and social restrictions?

This month we ask “How do you think the public has coped with the last year of lockdowns and social restrictions?”

The cost of COVID-19

Weekly COVID-19 testing, coupled with a two-week isolation period for positive cases, may be the most cost-effective strategy to tackle the spread of SARS-CoV-2 in the US when transmission is high until vaccines are widely available.

COVID-19: "Nanofibre swabs more sensitive"

Ultra-absorptive nanofibre swabs could reduce the number of false-negative tests by improving sample collection and test sensitivity, it is claimed.